StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
21
Publishing Date
2023 - 03 - 07
1
2023 - 03 - 02
1
2023 - 01 - 12
1
2023 - 01 - 05
1
2022 - 10 - 27
1
2022 - 10 - 24
1
2022 - 10 - 18
2
2022 - 10 - 06
1
2022 - 09 - 20
1
2022 - 09 - 07
1
2022 - 08 - 11
1
2022 - 03 - 10
1
2022 - 02 - 15
1
2021 - 11 - 24
1
2021 - 10 - 28
1
2021 - 10 - 25
1
2021 - 10 - 22
1
2021 - 08 - 11
1
2021 - 07 - 07
1
2021 - 06 - 24
1
Sector
Finance
1
Health technology
21
Tags
Acquisition
1
Agreement
1
Application
1
Approval
1
Benefits
1
Biomidwest
8
Cancer
21
Ces
1
China
1
City
1
Clearance
1
Clinical-trials-phase-iii
1
Conference
18
Day
1
Diagnostic
1
Earnings
5
Enroll
1
Events
6
Expected
2
Fda-approvals
1
Financial
5
Financial results
5
Ford
1
Global
3
Group
1
Growing
1
Health
6
International
1
Iot
7
Ipo
3
J.p. morgan healthcare conference
2
Life science
1
Market
8
Medical
1
Medical-device
1
Merge
1
Military
1
Money
1
Mridian
21
N/a
66
Nasdaq
2
Offering
6
Pancreas
1
Pancreatic
4
Partnership
1
People
2
Prostate cancer
4
Publication
3
Radiation therapy
8
Report
2
Research
4
Results
14
Services
3
State
2
Study
2
System
12
Therapy
34
Treatment
6
Trial
4
Viewray
27
Entities
Abbott laboratories
48
Abbvie inc.
53
Accuray incorporated
26
Agenus inc.
21
Agilent technologies, inc.
27
Amgen inc.
91
Anixa biosciences, inc.
49
Astellas pharma inc
49
Astrazeneca plc
144
Aveo pharmaceuticals, inc.
24
Becton, dickinson and company
26
Beigene, ltd.
58
Biocept, inc.
31
Biontech se
21
Blueprint medicines corporation
27
Briacell therapeutics corp.
50
Bristol-myers squibb company
107
Castle biosciences, inc.
28
Clovis oncology, inc.
33
Eli lilly and company
139
Exact sciences corporation
56
Exelixis, inc.
43
G1 therapeutics, inc.
27
Genprex, inc.
26
Gilead sciences, inc.
59
Glaxosmithkline plc
54
Guardant health, inc.
53
Hologic, inc.
32
Hoth therapeutics, inc.
29
Illumina, inc.
68
Immunitybio inc
29
Immunogen, inc.
25
Immutep limited
34
Incyte corporation
57
Invitae corporation
25
Jaguar health, inc.
36
Johnson & johnson
138
Karyopharm therapeutics inc.
27
Lantern pharma inc.
24
Lixte biotechnology holdings inc.
22
Merck & company, inc.
75
Merus n.v.
24
Mirati therapeutics, inc.
32
Myriad genetics, inc.
50
Nanostring technologies, inc.
22
Natera, inc.
38
Novartis ag
106
Novocure limited
30
Oncolytics biotech inc.
41
Orange
138
Pds biotechnology corporation
34
Pfizer, inc.
66
Qiagen n.v.
31
Regeneron pharmaceuticals, inc.
42
Sanofi
215
Seagen inc.
55
Takeda pharmaceutical company limited
34
Thermo fisher scientific inc
51
Veracyte, inc.
45
Verastem, inc.
25
Symbols
ARAY
3
GRTX
1
MS
1
VRAY
21
Exchanges
Nasdaq
21
Nyse
1
Crawled Date
2023 - 03 - 07
1
2023 - 03 - 02
1
2023 - 01 - 12
1
2023 - 01 - 05
1
2022 - 10 - 27
1
2022 - 10 - 24
1
2022 - 10 - 18
2
2022 - 10 - 06
1
2022 - 09 - 20
1
2022 - 09 - 07
1
2022 - 08 - 11
1
2022 - 03 - 10
1
2022 - 02 - 15
1
2021 - 11 - 24
1
2021 - 10 - 28
1
2021 - 10 - 25
1
2021 - 10 - 22
1
2021 - 08 - 11
1
2021 - 07 - 07
1
2021 - 06 - 24
1
Crawled Time
11:00
9
12:00
6
13:30
1
14:15
1
15:00
2
19:00
2
Source
www.biospace.com
4
www.prnewswire.com
17
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
entities :
Viewray, inc.
save search
Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients
Published:
2023-03-07
(Crawled : 12:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.39%
|
O:
0.98%
H:
1.82%
C:
-0.73%
mridian
system
military
therapy
cancer
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy
Published:
2023-03-02
(Crawled : 12:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.42%
|
O:
-1.15%
H:
1.17%
C:
-0.93%
mridian
therapy
cancer
Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published:
2023-01-12
(Crawled : 19:00)
- biospace.com/
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.43%
|
O:
0.92%
H:
4.17%
C:
3.85%
mridian
cancer
prostate cancer
Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment
Published:
2023-01-05
(Crawled : 15:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.41%
|
O:
0.7%
H:
15.35%
C:
7.91%
mridian
treatment
viewray
medical
cancer
MIRAGE Phase III Randomized Controlled Trial Demonstrates Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published:
2022-10-27
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.42%
|
O:
2.34%
H:
0.23%
C:
-4.79%
mridian
trial
cancer
prostate cancer
ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients
Published:
2022-10-24
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.36%
|
O:
1.78%
H:
6.0%
C:
4.0%
GRTX
|
$0.1833
-1.45%
-1.47%
800K
|
Health Technology
|
-89.22%
|
O:
3.59%
H:
0.0%
C:
-0.58%
viewray
cancer
study
pancreatic
Growing Awareness of the Benefits of Radiotherapy and the Increasing Use of Particle Therapy for Cancer Treatment is expected to Drive the Global Radiation Therapy Market | UnivDatos Market Insights
Published:
2022-10-18
(Crawled : 15:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.34%
|
O:
3.15%
H:
1.78%
C:
0.76%
ARAY
|
$2.135
-3.39%
-3.51%
630K
|
Health Technology
|
8.08%
|
O:
2.02%
H:
1.24%
C:
-3.96%
treatment
global
growing
expected
therapy
cancer
benefits
market
ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy
Published:
2022-10-18
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.34%
|
O:
3.15%
H:
1.78%
C:
0.76%
viewray
therapy
cancer
study
pancreatic
SUNY Upstate Cancer Center Chooses ViewRay's MRI-Guided Radiation Therapy System to Treat Cancer Patients
Published:
2022-10-06
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.35%
|
O:
1.57%
H:
1.68%
C:
-0.26%
system
therapy
cancer
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
Published:
2022-09-20
(Crawled : 11:00)
- prnewswire.com
MS
|
News
0 d
|
$90.66
0.44%
0.07%
8.1M
|
Finance
|
2.19%
|
O:
-0.7%
H:
0.4%
C:
-1.03%
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.32%
|
O:
-0.27%
H:
12.47%
C:
8.77%
viewray
program
therapy
cancer
ViewRay Announces China NMPA Approval of its MRIdian® MRI-Guided Radiation Therapy for Cancer Patients
Published:
2022-09-07
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.23%
|
O:
3.69%
H:
3.26%
C:
3.26%
mridian
viewray
approval
china
therapy
cancer
National Cancer Center Hospital in Tokyo Upgrades to MRIdian® Linac for MRI-Guided Radiation Therapy and has treated its first patients
Published:
2022-08-11
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.28%
|
O:
1.44%
H:
3.41%
C:
1.42%
mridian
therapy
cancer
First Toxicity Results from SCIMITAR Prospective Phase II Trial Signal Favorable Toxicity Profile of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer
Published:
2022-03-10
(Crawled : 12:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.37%
|
O:
1.01%
H:
0.5%
C:
-1.75%
prostate cancer
pos
state
trial
therapy
results
cancer
iot
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published:
2022-02-15
(Crawled : 12:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.43%
|
O:
3.4%
H:
1.1%
C:
-7.24%
mridian
prostate cancer
state
trial
therapy
cancer
iot
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
Published:
2021-11-24
(Crawled : 13:30)
- biospace.com/
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.55%
|
O:
-0.54%
H:
6.2%
C:
5.47%
therapy
cancer
radiation therapy
pancreatic
New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting
Published:
2021-10-28
(Crawled : 12:00)
- biospace.com/
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.63%
|
O:
1.47%
H:
4.05%
C:
3.32%
cancer
pancreatic
pancreas
Helsinki University Hospital Selects MRIdian® System for Installation at Comprehensive Cancer Center
Published:
2021-10-25
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.63%
|
O:
1.48%
H:
4.31%
C:
2.19%
cancer
Global Radiation Oncology Markets, 2021-2028 - Increasing Application Of Radiopharmaceuticals, Rising Prevalence Of Cancer, & Rising Adoption Of Radiotherapy
Published:
2021-10-22
(Crawled : 19:00)
- prnewswire.com
ARAY
|
$2.135
-3.39%
-3.51%
630K
|
Health Technology
|
Email alert
Add to watchlist
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
Email alert
Add to watchlist
application
therapy
cancer
iot
Radiotherapy Market Size to Reach USD 7.65 Billion in 2027 | Increasing Global Incidence of Cancer, Rising Use of Radiotherapy in Combination with Other Treatment Approaches are Some Key Factors Driving Industry Demand, says Emergen Research
Published:
2021-08-11
(Crawled : 14:15)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.58%
|
O:
0.0%
H:
0.67%
C:
-4.88%
ARAY
|
$2.135
-3.39%
-3.51%
630K
|
Health Technology
|
-46.9%
|
O:
-0.5%
H:
0.0%
C:
-1.0%
treatment
therapy
cancer
research
iot
merge
Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial
Published:
2021-07-07
(Crawled : 11:00)
- prnewswire.com
VRAY
|
$0.025
-39.9%
-61.87%
110M
|
Health Technology
|
-99.62%
|
O:
1.96%
H:
1.63%
C:
-1.63%
therapy
cancer
radiation therapy
trial
enroll
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.